EU approval for SOLATENOL™ fungicide

• Delivers outstanding control of major European cereal diseases
• Basis for many new combination products
• Expected first sales in France for 2016/2017 season

Syngenta announced today that its SDHI fungicide SOLATENOL™ has been approved by the EU authorities. This registration will allow Syngenta to introduce a number of new offers for the European cereal market. First sales of SOLATENOL™ in France are expected for the 2016/2017 season, with a total peak sales potential in Europe of $200 million.

SOLATENOL™ is an SDHI fungicide offering an unrivaled performance against Septoria and rusts - two important diseases in Europe which can significantly impact cereals production. In trials, it has proven to be extremely consistent in providing excellent disease control on all important cereal varieties in a wide range of situations over several years. SOLATENOL™ offers outstanding levels of leaf protection resulting in higher yield and return on investment for the farmer.   

Syngenta COO, Jon Parr, said: “SOLATENOL’s approval enables us to introduce new offers to meet the needs of European growers. This registration demonstrates the scale of our new product introductions and underpins Syngenta's global leadership in fungicides. We are delighted that we can bring another winning innovation into the hands of growers.”

SOLATENOL™ is already available to growers in Latin America as ELATUS™, achieving sales of more than $300 million in its first year in Brazil. In 2015 it also received approval in the USA and Canada.

About Syngenta

Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter® at www.twitter.com/Syngenta

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract there for.